Aortic stenosis (AS) represents the most common primary valve disease leading to surgery or catheter intervention in Europe and North America, with an increasing prevalence due to the aging population. Transcatheter aortic valve replacement (TAVR) has been shown to be superior in terms of mortality to medical therapy in extreme-risk patients and noninferior or superior to surgery in high-risk patients. The percutaneous balloon aortic valvuloplasty (BAV) is actually recommended by the European Society of Cardiology guidelines as a bridge to surgery or TAVR or as a diagnostic means in patients with severe AS and particular clinical settings.
Two-Year-Survival Rate of High-Risk Elderly Patients With Severe Aortic Stenosis Treated With Perfusion-Balloon Valvuloplasty Without Rapid Pacing / Scalone, Giancarla; Aimi, Alessandro; Bruscoli, Filippo; Ciommi, Mariateresa; Giusto, Federico Di; Vito, Luca Di; Mariani, Luca; Silenzi, Simona; Grossi, Pierfrancesco. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - 209:(2023), pp. 220-223. [10.1016/j.amjcard.2023.09.059]